AGTXOTCBiological Products, (No Diagnostic Substances)Fiscal year ends March 31
Agentix Corp.
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$0.02+0.00 (0.00%)
Close on Oct 16, 2026
- Market cap
- $801.34K
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.0299 (−59.92%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $801.34K
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- -$417.49K
- EPS, diluted
- $0.00
- Book value per share
- -$0.09
- Diluted shares
- 40M
Twelve years at a glance
Fiscal years 2013 to 2026 and trailing twelve months, USD
Revenue
–
Gross profit
–
Operating income
-$340.35K
Net income
-$417.49K
EPS, diluted
$0.00
Free cash flow
–
Reported periodTrailing twelve months